New gel shows promise in shrinking painful skin tumors
Disease control
Completed
This study tested whether a gel called NFX-179 could safely reduce the size of skin tumors in adults with neurofibromatosis type 1 (NF1). 199 participants applied the gel or a placebo to 10 specific tumors on their face, chest, or arms once daily for six months. Researchers measu…
Phase: PHASE2 • Sponsor: NFlection Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC